Multiple Cities, Denmark
NCT Number: NCT00395395
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women
This is a phase I study to analyze the effect of water and food intake on the bioavailability and pharmacodynamic of oral salmon calcitonin (SMC021) and salmon calcitonin nasal spray in post-menopausal women.
Looking for future studies?
Notify MeKey information
Conditions
Age range
40 year–70 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 1
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy postmenopausal women
Exclusion criteria
- Previous treatment with other osteoporosis medication
Other protocol defined inclusion/exclusion criteria may apply.
Treatment and study plan
Oral salmon calcitonin, salmon calcitonin nasal spray
DrugPrimary outcomes
-
Pharmacokinetic (PK) profile of oral salmon calcitonin taken in the morning with 50 ml or 200 ml water and at 10, 30 or 60 minutes before a meal
Secondary outcomes
-
Pharmacodynamic (PD) profile of oral salmon calcitonin taken in the morning with 50 ml or 200 ml water and at 10, 30 or 60 minutes before a meal
-
PK profile of the carrier of oral salmon calcitonin, taken in the morning with 50 ml or 200 ml water and at 10, 30 or 60 minutes before a meal
-
PK profile of salmon calcitonin nasal spray
Sponsors and collaborators
Lead sponsor
Novartis
Industry
Registry information
Official study title
A Partially-Blind, Randomized, Single-Dose, Placebo-Controlled Crossover Phase I Study Assessing the Effect of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of SMC021 0.8 mg in Healthy Postmenopausal Women
Important dates
- Study start
- 2006
- First posted
- Nov 2, 2006
- Registry last updated
- May 28, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Progressive Strength and Balance Exercise for Fall Prevention in Postmenopausal Women With Osteoporosis
NCT07685392
Accidental Falls, Aged, Exercise Movement Techniques, Bone Diseases
Mexico City, Mexico
View Trial DetailsA Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
NCT06079476
Bone Diseases, Bone Diseases, Metabolic
Ahmedabad, Gujarat, India
View Trial DetailsBlackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk
NCT04431960
Bone Diseases, Bone Diseases, Metabolic
Storrs, Connecticut, United States
View Trial DetailsAlendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
NCT04338529
Bone Diseases, Bone Diseases, Metabolic
Athens, Attica, Greece
View Trial Details